Contact

Still Threshold 23 Home About Services Mechanisms Human Evidence Research Roadmap Contact Evidence, mechanisms & safety Ibogaine And The Brain: Neuroplasticity Explained A careful look at what early science suggests about ibogaine, neural adaptation, addiction, and the important distance between biological plausibility and proven treatment. Independent information, not medical advice Biology is a beginning, not a guarantee. Start with the material What is ibogaine and how does it interact with the brain? Ibogaine is an indole alkaloid derived from the root bark of the Tabernanthe iboga shrub, native to West Africa. Historically, iboga has been used in spiritual and healing ceremonies by indigenous cultures for centuries. It is classified as a psychedelic substance because of its psychoactive effects and capacity to induce altered states of consciousness; the broader cultural and botanical context is summarized in the Tabernanthe iboga reference entry . Ibogaine has a long, often intense experience and is metabolized partly into noribogaine, an active compound with a longer duration of action. Both compounds have a wide receptor profile, which makes a single, simple mechanism of action unlikely. This complexity is central to discussions of ibogaine and addiction treatment. Ibogaine and noribogaine interact with serotonin, dopamine, glutamate receptors, and opioid-related systems in the central nervous system. Receptor binding also reaches the alpha3beta4 nicotinic acetylcholine receptor and kappa opioid receptor, so the neurobiological picture is multi-layered rather than a one-switch reset. For people encountering treatment claims, resources such as ibogaine treatment information in Baja may describe care pathways, while independent reading should keep the evidence limits in view. Ibogaine remains unregulated or illegal in many countries, and its use is typically confined to specialized clinics where it is permitted. A working definition Neuroplasticity is the b

A considered point of contact.